The API division recorded a turnover of ₹609 crore in FY25, accounting for 8.35% of the company’s consolidated revenue. Its net worth stood at ₹666.5 crore as of March 31, 2025, contributing 10.68% of the company’s consolidated net worth. Shares of Jubilant Pharmova Ltd ended at ₹1,125, down by ₹19.90, or 1.74%, on the BSE.
Source link
